Upstream Bio, Inc.
General ticker "UPB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $900.8M (TTM average)
Upstream Bio, Inc. does not follow the US Stock Market performance with the rate: -23.4%.
Estimated limits based on current volatility of 2.3%: low 5.25$, high 5.50$
Factors to consider:
- Total employees count: 75 (+44.2%) as of 2025
- Top business risk factors: Limited operating history, Need additional capital, Operational and conduct risks, Product development failure, Regulatory and compliance
- Current price 62.2% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [14.13$, 36.19$]
- 2026-12-31 to 2027-12-31 estimated range: [8.68$, 23.91$]
Short-term UPB quotes
Long-term UPB plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $2.38MM | $2.37MM | $2.85MM |
| Operating Expenses | $42.49MM | $80.13MM | $163.22MM |
| Operating Income | $-40.11MM | $-77.76MM | $-160.36MM |
| Non-Operating Income | $19.58MM | $14.96MM | $16.92MM |
| R&D Expense | $31.80MM | $62.97MM | $136.81MM |
| Income(Loss) | $-20.54MM | $-62.81MM | $-143.44MM |
| Net Income(Loss)* | $-20.54MM | $-62.81MM | $-143.44MM |
| Stockholders Equity | $-123.13MM | $469.85MM | $339.77MM |
| Assets | $117.20MM | $481.72MM | $353.77MM |
| Operating Cash Flow | $-37.93MM | $-59.17MM | $-133.28MM |
| Capital expenditure | $0.14MM | $0.51MM | $0.17MM |
| Investing Cash Flow | $-82.84MM | $-59.48MM | $-93.48MM |
| Financing Cash Flow | $129.55MM | $418.91MM | $2.44MM |
| Earnings Per Share** | $-0.57 | $-1.22 | $-2.66 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.